Related Experiment Videos

Hypocalcemic heart failure in thalassemic patients

M Tsironi1, K Korovesis, D Farmakis

  • 1First Department of Internal Medicine, University of Athens, Medical School, Laiko Hospital, Athens, Greece. gpoyl@otenet.gr

International Journal of Hematology
|June 8, 2006
PubMed

Insights

Hypocalcemic cardiomyopathy in hypoparathyroidism often resists standard heart failure treatment. Correcting hypocalcemia in a thalassemia patient significantly improved cardiac function, supporting this link.

Area of Science:

  • Cardiology
  • Endocrinology
  • Hematology

Background:

  • Hypocalcemic cardiomyopathy associated with hypoparathyroidism is typically resistant to conventional heart failure therapies.
  • Thalassemia patients can experience cardiac complications from factors including hemosiderosis and electrolyte imbalances.

Observation:

  • A thalassemia patient presented with severe cardiac failure, unresponsive to standard treatments.
  • Cardiac evaluation revealed impaired biventricular function, and lab results indicated hypoparathyroidism secondary to hemosiderosis and hypocalcemia.

Findings:

  • Treatment focused on addressing hypocalcemia through calcium supplementation led to significant clinical and echocardiographic improvement.
  • This suggests hypocalcemia was a primary driver of the cardiomyopathy in this case.

Implications:

  • This case highlights the critical role of calcium homeostasis in cardiac function, particularly in patients with hypoparathyroidism.
  • It underscores the importance of investigating and treating hypocalcemia in refractory cardiac failure, especially in susceptible patient populations.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...